Han, S., Xu, Y., Chen, D., Yang, F., Wang, M., Zhou, Q., . . . Xing, N. (2024). Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors. iScience, 27(1), . https://doi.org/10.1016/j.isci.2023.108290
Chicago-referens (17:e uppl.)Han, Sujun, et al. "Notch Activation Defines Immune-suppressive Subsets of CcRCCs with Unfavorable Benefits from Immunotherapy over VEGFR/mTOR Inhibitors." IScience 27, no. 1 (2024). https://doi.org/10.1016/j.isci.2023.108290.
MLA-referens (9:e uppl.)Han, Sujun, et al. "Notch Activation Defines Immune-suppressive Subsets of CcRCCs with Unfavorable Benefits from Immunotherapy over VEGFR/mTOR Inhibitors." IScience, vol. 27, no. 1, 2024, https://doi.org/10.1016/j.isci.2023.108290.
